Franziska Brauneck (Brauneck Franziska, F Brauneck)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Venues

Journal for immunotherapy of cancer

Oncoimmunology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Witt Marius, Oliveira-Ferrer Leticia, Koch-Nolte Friedrich, Menzel Stephan, Hell Louisa, Sturmheit Tabea, Seubert Elisa, Weimer Pauline, Ding Yi, Minyue Qi, Schmalfeldt Barbara, Bokemeyer Carsten, Fiedler Walter, Wellbrock Jasmin, Franziska Brauneck
Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction. Oncoimmunology 13 (1) (2024)
Witt Marius, Oliveira-Ferrer Leticia, Koch-Nolte Friedrich, Menzel Stephan, Hell Louisa, Sturmheit Tabea, Seubert Elisa, Weimer Pauline, Ding Yi, Minyue Qi, Schmalfeldt Barbara, Bokemeyer Carsten, Fiedler Walter, Wellbrock Jasmin, Franziska Brauneck
Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction. Oncoimmunology 13 (1) (2024)
Felix Klingler, Winfried H Alsdorf, Susanne Ghandili, Christine Wolschke, Franziska Brauneck, Carsten Bokemeyer, Walter Fiedler, Franziska Modemann, Panagiotis Karagiannis
Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia including CPX-351, cytarabine/daunorubicin with and without the addition of cladribine. Leukemia & lymphoma 63 (11) (2022)
Franziska Brauneck, Brit Fischer, Marius Witt, Jana Muschhammer, Jennyfer Oelrich, Pedro Henrique da Costa Avelar, Sophia Tsoka, Lars Bullinger, Elisa Seubert, Daniel J Smit, Carsten Bokemeyer, Christin Ackermann, Jasmin Wellbrock, Friedrich Haag, Walter Fiedler
TIGIT blockade repolarizes AML-associated TIGIT + M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis. Journal for immunotherapy of cancer 10 (12) (2022)
Franziska Brauneck, Brit Fischer, Marius Witt, Jana Muschhammer, Jennyfer Oelrich, Pedro Henrique da Costa Avelar, Sophia Tsoka, Lars Bullinger, Elisa Seubert, Daniel J Smit, Carsten Bokemeyer, Christin Ackermann, Jasmin Wellbrock, Friedrich Haag, Walter Fiedler
TIGIT blockade repolarizes AML-associated TIGIT + M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis. Journal for immunotherapy of cancer 10 (12) (2022)
Franziska Brauneck, Brit Fischer, Marius Witt, Jana Muschhammer, Jennyfer Oelrich, Pedro Henrique da Costa Avelar, Sophia Tsoka, Lars Bullinger, Elisa Seubert, Daniel J Smit, Carsten Bokemeyer, Christin Ackermann, Jasmin Wellbrock, Friedrich Haag, Walter Fiedler
TIGIT blockade repolarizes AML-associated TIGIT + M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis. Journal for immunotherapy of cancer 10 (12) (2022)
Franziska Brauneck, Brit Fischer, Marius Witt, Jana Muschhammer, Jennyfer Oelrich, Pedro Henrique da Costa Avelar, Sophia Tsoka, Lars Bullinger, Elisa Seubert, Daniel J Smit, Carsten Bokemeyer, Christin Ackermann, Jasmin Wellbrock, Friedrich Haag, Walter Fiedler
TIGIT blockade repolarizes AML-associated TIGIT + M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis. Journal for immunotherapy of cancer 10 (12) (2022)
Franziska Brauneck, F Haag, R Woost, N Wildner, E Tolosa, A Rissiek, G Vohwinkel, J Wellbrock, C Bokemeyer, J Schulze Zur Wiesch, C Ackermann, W Fiedler
Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML. Oncoimmunology 10 (1) (2021)

Franziska Brauneck.css-eqlu8i{font-size:small;padding-left:4px;} (Brauneck Franziska, F Brauneck)

Publication Activity (10 Years)

Top Topics

Top Venues

Franziska Brauneck (Brauneck Franziska, F Brauneck)